Clinical Trials Directory

Trials / Completed

CompletedNCT02271971

Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis

Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Moderate to Severe Psoriasis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Pontificia Universidad Catolica de Chile · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether supplementation with oral vitamin D (cholecalciferol) improves metabolic parameters in patients with moderate to severe psoriasis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D3A daily 5.000 IU vitamin D3 capsule during 6 weeks.
DIETARY_SUPPLEMENTPlaceboA daily placebo capsule during 6 weeks.

Timeline

Start date
2014-10-01
Primary completion
2015-04-01
Completion
2015-10-01
First posted
2014-10-22
Last updated
2015-11-04

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT02271971. Inclusion in this directory is not an endorsement.

Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis (NCT02271971) · Clinical Trials Directory